NDSIB
RMD icon

North Dakota State Investment Board’s ResMed RMD Stock Holding History

North Dakota State Investment Board’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$947K Sell
4,220
-786
-16% -$196K 0.04% 318
2025
Q4 		$1.21M Buy
+5,006
New +$1.28M 0.04% 313

Other funds holding RMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

North Dakota State Investment Board's RMD Position: Q1 2026 in Review

North Dakota State Investment Board reduced its ResMed (RMD) stake by 16% in Q1 2026, selling an estimated $196K and leaving 4,220 shares worth $947K. The position accounts for 0.04% of the portfolio, ranked #318.

North Dakota State Investment Board first reported a position in RMD in Q4 2025 and has held it in 2 quarters since. The position peaked at $1.21M in Q4 2025. 939 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • North Dakota State Investment Board held 4,220 shares of ResMed worth $947K as of Q1 2026.
  • North Dakota State Investment Board sold 786 ResMed shares in Q1 2026, an estimated $196K.
  • ResMed made up 0.04% of North Dakota State Investment Board's portfolio in Q1 2026, its #318 holding.
  • North Dakota State Investment Board first reported a position in ResMed in Q4 2025 and has held it in 2 quarters since.
  • North Dakota State Investment Board's ResMed position peaked at $1.21M in Q4 2025.
  • 939 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on North Dakota State Investment Board's 13F filing for Q1 2026, filed 8 May 2026.